You are here

  • Home
  • Archive
  • Volume 33, Issue Suppl 4
  • PR069/#709  Prognostic impact of erythropoietin-stimulating agents during front-line chemotherapy in patients with ovarian cancer: a Korean multicenter cohort study

Alerts

Article menu

Download PDFPDF

Featured Posters: Poster Rounds with the Professors
AS11. Ovarian cancer
PR069/#709  Prognostic impact of erythropoietin-stimulating agents during front-line chemotherapy in patients with ovarian cancer: a Korean multicenter cohort study
Free
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address